封面
市場調查報告書
商品編碼
1796891

先進球囊導管市場-全球產業規模、佔有率、趨勢、機會和預測,按原料類型、應用、最終用戶、地區和競爭細分,2020-2030 年

Advanced Balloon Catheter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Raw Material Type, By Application, End Users, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球高級球囊導管市場價值為 42.2 億美元,預計到 2030 年將達到 71.9 億美元,預測期內的複合年成長率為 9.29%。全球高級球囊導管市場正在經歷顯著成長,這得益於該地區各種慢性心臟病患病率的上升和老齡人口的成長。新興國家對微創手術的需求不斷成長,以及先進心血管設備的發展,將在預測期內進一步增強球囊導管的整體市場需求。其他支持市場成長的因素包括影響泌尿系統的骨盆腔癌症發生率不斷上升,以及旨在將藥物輸送到作用部位的藥物塗層球囊導管的技術發展,預計這些都將推動市場的成長。

市場概覽
預測期 2026-2030
2024年市場規模 42.2億美元
2030年市場規模 71.9億美元
2025-2030 年複合年成長率 9.29%
成長最快的領域 神經血管手術
最大的市場 北美洲

關鍵市場促進因素

心血管和周邊動脈疾病發生率上升

主要市場挑戰

先進設備和程序的成本高昂

主要市場趨勢

藥物塗層球囊(DCB)的使用日益增多

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:全球先進球囊導管市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依原料種類(尼龍、PET、聚氨酯、其他)
    • 依應用(冠狀動脈手術、周邊手術、神經血管手術、其他手術)
    • 按最終使用者(醫院和門診手術中心、導管室等)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第6章:北美高級球囊導管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲先進球囊導管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章:亞太地區高級球囊導管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美洲高級球囊導管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲高級球囊導管市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 併購
  • 產品發布

第 13 章:全球高級球囊導管市場:SWOT 分析

第 14 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章:競爭格局

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Meril Life Sciences Pvt. Ltd.
  • Hexacath
  • Tokai Medical Products Inc.
  • Cook Medical Inc.

第 16 章:策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 14331

Global Advanced Balloon Catheter Market was valued at USD 4.22 billion in 2024 and is expected to reach USD 7.19 billion by 2030 with a CAGR of 9.29% during the forecast period. The global market for Advanced Balloon Catheter is experiencing significant growth, driven by the rising prevalence of different chronic heart diseases and growing geriatric populations across the region. The increasing demand for minimally invasive procedures in emerging countries and the development of advanced cardiovascular devices will further enhance the overall market demand for balloon catheters during the forecast period. The other factors supporting the market's growth are the growing incidence of cancers in the pelvic region affecting the urinary system along with the technical development of drug-coated balloon catheters aimed at drug delivery at the site of action is expected to propel the growth of the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.22 Billion
Market Size 2030USD 7.19 Billion
CAGR 2025-20309.29%
Fastest Growing SegmentNeurovascular Procedures
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Cardiovascular and Peripheral Arterial Diseases

The global burden of cardiovascular disease (CVD) continues to be a leading cause of death and disability. According to the World Health Organization (WHO), CVDs account for over 17.9 million deaths annually, making them the top cause of mortality worldwide. A substantial proportion of these cases involve atherosclerosis, coronary artery disease (CAD), and peripheral artery disease (PAD)all conditions for which balloon catheters are a critical component of diagnosis and treatment, particularly in angioplasty procedures.

Balloon catheters help open narrowed or blocked blood vessels without requiring more invasive surgeries, which has made them highly favored in both emergency and elective interventions. In regions with aging populations, especially North America and parts of Europe, the demand for minimally invasive vascular procedures has steadily increased due to the higher prevalence of hypertension, diabetes, and obesity.

Key Market Challenges

High Cost of Advanced Devices and Procedures

One of the most pressing challenges facing the global advanced balloon catheter market is the high cost associated with these devices, which can limit their accessibility, especially in low- and middle-income countries. Drug-coated and specialty catheters are significantly more expensive than conventional balloon catheters, making their widespread use a financial burden for both healthcare systems and patients. Even in high-income countries, insurance coverage does not always fully reimburse advanced interventional procedures. In publicly funded healthcare systems, budget constraints and cost-containment policies often result in delayed or limited adoption of newer, costlier technologies. The challenge is further compounded by the need for specialized training and infrastructure, which increases the total cost of ownership for hospitals and surgical centers.

Government funding programs, while helpful, are often insufficient to address the gap in demand for cutting-edge equipment versus what is affordable or reimbursable. This disparity limits the penetration of advanced balloon catheter technology in various parts of the world, hindering equitable healthcare delivery.

Key Market Trends

Growing Use of Drug-Coated Balloons (DCBs)

Drug-coated balloons are gaining significant traction as they offer a stent-less solution for revascularization. These devices are particularly useful in treating in-stent restenosis (ISR) and femoral-popliteal lesions, where stents may not be ideal due to anatomical or movement-related factors. The appeal of DCBs lies in their ability to deliver therapeutic agents like paclitaxel directly into the vessel wall during a short inflation time, reducing the risk of chronic inflammation and improving healing outcomes.

Healthcare systems are showing increasing interest in DCBs, especially for peripheral interventions. Clinical trials supported by government agencies such as the National Institutes of Health (NIH) in the U.S. have investigated the long-term efficacy and safety of these devices, providing a research-backed push toward greater adoption. This trend is expected to grow further as more biocompatible and biodegradable drug coatings are introduced and regulatory bodies clarify safety profiles, making DCBs a mainstay in future vascular treatments.

Key Market Players

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Meril Life Sciences Pvt. Ltd.
  • Hexacath
  • Tokai Medical Products Inc.
  • Cook Medical Inc.

Report Scope:

In this report, the Global Advanced Balloon Catheter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Advanced Balloon Catheter Market, By Raw Material Type:

  • Nylon
  • PET
  • Polyurethane
  • Others

Advanced Balloon Catheter Market, By Application:

  • Coronary Procedures
  • Peripheral Procedures
  • Neurovascular Procedures
  • Other Procedures

Advanced Balloon Catheter Market, By End User:

  • Hospitals and Ambulatory Surgical Centres
  • Catheterization Laboratories
  • Others

Advanced Balloon Catheter Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Advanced Balloon Catheter Market.

Available Customizations:

Global Advanced Balloon Catheter Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Advanced Balloon Catheter Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 5.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 5.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Advanced Balloon Catheter Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 6.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 6.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Advanced Balloon Catheter Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Raw Material Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Advanced Balloon Catheter Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Raw Material Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Advanced Balloon Catheter Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Raw Material Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Advanced Balloon Catheter Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 7.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 7.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Advanced Balloon Catheter Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Raw Material Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Advanced Balloon Catheter Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Raw Material Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Advanced Balloon Catheter Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Raw Material Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Advanced Balloon Catheter Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Raw Material Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Advanced Balloon Catheter Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Raw Material Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Advanced Balloon Catheter Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 8.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 8.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Advanced Balloon Catheter Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Raw Material Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Advanced Balloon Catheter Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Raw Material Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Advanced Balloon Catheter Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Raw Material Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Advanced Balloon Catheter Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Raw Material Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Advanced Balloon Catheter Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Raw Material Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Advanced Balloon Catheter Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 9.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 9.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Advanced Balloon Catheter Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Raw Material Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Advanced Balloon Catheter Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Raw Material Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Advanced Balloon Catheter Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Raw Material Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Advanced Balloon Catheter Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Raw Material Type (Nylon, PET, Polyurethane, Others)
    • 10.2.2. By Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, Other Procedures)
    • 10.2.3. By End Users (Hospitals and Ambulatory Surgical Centres, Catheterization Laboratories, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Advanced Balloon Catheter Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Raw Material Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Advanced Balloon Catheter Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Raw Material Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Advanced Balloon Catheter Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Raw Material Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Advanced Balloon Catheter Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Boston Scientific Corporation
  • 15.3. Medtronic plc
  • 15.4. Terumo Corporation
  • 15.5. MicroPort Scientific Corporation
  • 15.6. B. Braun Melsungen AG
  • 15.7. Meril Life Sciences Pvt. Ltd.
  • 15.8. Hexacath
  • 15.9. Tokai Medical Products Inc.
  • 15.10. Cook Medical Inc.

16. Strategic Recommendations

17. About Us & Disclaimer